MRK vs HCA
By Alex · Tickerpine
Merck & Co., Inc. vs HCA Healthcare, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | HCA |
|---|---|---|
| Price | $156.45 | $428.76 |
| Market cap | $385.99B | $92.83B |
| P/E ratio | 120.3 | 14.4 |
| ROE | 6.96% | — |
| Profit margin | 4.77% | 8.77% |
| Revenue growth | 5.10% | 8.70% |
| Dividend yield | 2.26% | 0.73% |
| Beta | 0.21 | 1.11 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs HCA in plain English
- MRK is the bigger company — about 4.2× the market cap of HCA.
- HCA is cheaper on earnings (P/E 14.4 vs 120.3).
- HCA is growing revenue faster (9% vs 5%).
- MRK has the higher dividend yield (2.26% vs 0.73%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
HCA return calculator
See what $1,000 in HCA Healthcare, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.